Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PE(40:5e)/PE(40:4p) | Lipid-depleted/compactin | 0.0 | BCD100427B002 | 206 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | Lipid-depleted/compactin | 0.5 | BCD100427B005 | 373 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | Lipid-depleted/compactin | 1.0 | BCD100427B009 | 359 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | Lipid-depleted/compactin | 2.0 | BCD100427B013 | 207 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | Lipid-depleted/compactin | 4.0 | BCD100427B017 | 176 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | Lipid-depleted/compactin | 8.0 | BCD100427B021 | 158 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | Lipid-depleted/compactin | 12.0 | BCD100427B025 | 58.1 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | Lipid-depleted/compactin | 24.0 | BCD100427B029 | 119 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | C | 0.0 | BCD100427B001 | 136 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | C | 0.5 | BCD100427B003 | 262 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | C | 1.0 | BCD100427B007 | 537 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | C | 2.0 | BCD100427B011 | 214 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | C | 4.0 | BCD100427B015 | 260 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | C | 8.0 | BCD100427B019 | 152 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | C | 12.0 | BCD100427B023 | 131 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | C | 24.0 | BCD100427B027 | 72.1 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100427B006 | 218 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100427B010 | 224 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100427B014 | 211 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100427B018 | 189 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100427B022 | 172 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100427B026 | 42.8 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100427B030 | 97.1 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | 25OH-Chol | 0.5 | BCD100427B004 | 527 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | 25OH-Chol | 1.0 | BCD100427B008 | 246 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | 25OH-Chol | 2.0 | BCD100427B012 | 492 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | 25OH-Chol | 4.0 | BCD100427B016 | 304 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | 25OH-Chol | 8.0 | BCD100427B020 | 91.1 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | 25OH-Chol | 12.0 | BCD100427B024 | 178 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | 25OH-Chol | 24.0 | BCD100427B028 | 24 | pmol/sample |